AIHealthcare

H2O.ai is a privately held enterprise AI software company founded in 2012 and headquartered in Mountain View, California. It develops open-source and commercial machine-learning, automated machine-learning, predictive AI, generative AI, explainable AI, and AI application-development products, including H2O-3, Driverless AI, H2O AI Cloud, and H2O Wave. In healthcare and life sciences, its platform is positioned as an enabling technology rather than a single-purpose clinical device, supporting use cases such as clinical decision support, patient-risk stratification, readmission and no-show prediction, hospital-capacity management, population health, precision medicine, claims analytics, fraud detection, and pharmaceutical research. The company reports customers or healthcare relationships including Kaiser Permanente, Bon Secours Mercy Health, Change Healthcare, HCA, Walgreens, and GlaxoSmithKline, and states that it serves more than 20,000 organizations globally. Its market position is that of an enterprise AI/AutoML platform vendor competing through open-source adoption, automated model development, explainability, deployment flexibility, and support for private, on-premises, and cloud environments—particularly relevant to regulated sectors such as healthcare and financial services. Publicly reported financing indicates a $100 million Series E in November 2021 at approximately a $1.6–$1.7 billion valuation; third-party sources report cumulative funding of approximately $250–$251 million, but totals vary by source and no more recent major primary financing announcement was identified. H2O.ai is not a public company, and independently verified current revenue, market share, and current valuation were not available.